1-5 of 5
Judith Goldberg
Close
Sort by
Journal Articles

Post-Transplant Cyclophosphamide, Abatacept and Short Course of Tacrolimus (CAST) for Graft-Versus-Host Disease Prevention Following Haploidentical Peripheral Blood Stem Cell Transplantation

A Samer Al-Homsi, Frank Cirrone, Kelli Cole, Jaime Andres Suarez-Londono, Sharon L. Gardner, Jingmei Hsu, Stephanie Wo, Kelsey Stocker, Benedetto Bruno, Judith Goldberg, Benjamin Levinson, Maher Abdul-Hay
Journal: Blood
Blood (2022) 140 (Supplement 1): 7628–7630.
https://doi.org/10.1182/blood-2022-162634
Published: 2022
Journal Articles

Post-Transplant High Dose Cyclophosphamide and Bortezomib As Graft-Versus-Host Disease Prophylaxis Following Allogeneic Hematopoietic Stem Cell Transplantation

Benedetto Bruno, Frank Cirrone, Kelli Cole, Kelsey Stocker, Maher Abdul-Hay, J Andres Suarez-Londono, Tsivia Hochman, Judith Goldberg, A Samer Samer Al-Homsi
Journal: Blood
Blood (2021) 138 (Supplement 1): 3892.
https://doi.org/10.1182/blood-2021-151809
Published: 2021
Journal Articles

Post-Transplant Cyclophosphamide, Abatacept, and Short Course of Tacrolimus Combination (CAST) Is Safe and Seems Highly Effective in Preventing Graft-Versus-Host Disease Following Haploidentical Peripheral Blood Stem Cell Transplantation

A Samer Samer Al-Homsi, Frank Cirrone, Kelli Cole, Kelsey Stocker, Benedetto Bruno, J Andres Suarez-Londono, Judith Goldberg, Maher Abdul-Hay
Journal: Blood
Blood (2021) 138 (Supplement 1): 3906.
https://doi.org/10.1182/blood-2021-150856
Published: 2021
Journal Articles

A Multi-Center Retrospective Review of COVID-19 Outcomes in Patients with Lymphoid Malignancy

Yun Choi, Jessica Caro, Xiaochun Li, Arshed Al-Obeidi, Sharyn Lynn Kurtz, Austin I. Kim, Julie E. Chang, Adam J. Olszewski, Adam Zayac, Andrew Matthews, Stefan K. Barta, Suchitra Sundaram, Francisco J. Hernandez-Ilizaliturri, Lori A. Leslie, Paolo Caimi, Jordan Carter, Kevin A. David, Andrew M. Evens, Myung Sun Kim, Sarah J. Nagle, Judith Goldberg, Catherine S. Diefenbach
Journal: Blood
Blood (2021) 138 (Supplement 1): 184.
https://doi.org/10.1182/blood-2021-146398
Published: 2021
Journal Articles

A Phase I Study of the Proteasome Inhibitor Bortezomib in Patients with Myelofibrosis.

Giovanni Barosi, MD, Elisabetta Gattoni, MD, Tiziano Barbui, MD, Alessandro M. Vannucchi, MD, Alessandro Rambaldi, MD, Lewis Silverman, MD, Judith Goldberg, MD, Roberto Marchioli, MD, Ronald Hoffman, MD
Journal: Blood
Blood (2007) 110 (11): 3540.
https://doi.org/10.1182/blood.V110.11.3540.3540
Published: 2007